Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.08 EUR | -1.89% | +38.67% | -21.80% |
Mar. 25 | Advicenne: ODD designation in cystinuria | CF |
Jan. 24 | Advicenne: share price hit after 2023 sales figures | CF |
Sales 2023 | 2.94M 3.17M | Sales 2024 * | 4.2M 4.53M | Capitalization | 25.63M 27.62M |
---|---|---|---|---|---|
Net income 2023 | -7M -7.54M | Net income 2024 * | -7M -7.54M | EV / Sales 2023 | 11.1 x |
Net Debt 2023 * | 8.25M 8.89M | Net Debt 2024 * | 22.7M 24.46M | EV / Sales 2024 * | 11.5 x |
P/E ratio 2023 |
-3.97
x | P/E ratio 2024 * |
-3.25
x | Employees | 19 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 88.22% |
1 day | -1.89% | ||
1 week | +38.67% | ||
Current month | +69.66% | ||
1 month | +54.99% | ||
3 months | -21.51% | ||
6 months | -10.34% | ||
Current year | -21.80% |
Managers | Title | Age | Since |
---|---|---|---|
Didier Laurens
CEO | Chief Executive Officer | 59 | 21-05-02 |
Chief Tech/Sci/R&D Officer | - | 23-03-31 | |
André Ulmann
BRD | Director/Board Member | - | 17-06-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | - | 11-04-28 | |
Catherine Dunand
BRD | Director/Board Member | 62 | 17-03-08 |
Didier Laurens
CEO | Chief Executive Officer | 59 | 21-05-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 2.08 | -1.89% | 115,530 |
24-03-27 | 2.12 | +3.67% | 45,897 |
24-03-26 | 2.045 | -11.09% | 132,575 |
24-03-25 | 2.3 | +39.39% | 404,396 |
24-03-22 | 1.65 | +10.00% | 89,490 |
Real-time Euronext Paris, March 28, 2024 at 12:35 pm EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.80% | 28.27M | |
+0.44% | 90.27B | |
+9.61% | 44.05B | |
-16.67% | 31.45B | |
+44.99% | 23.35B | |
-9.42% | 16.72B | |
-25.92% | 15.09B | |
-9.27% | 12.82B | |
-7.57% | 11.95B | |
+0.07% | 8.71B |